PKLR and neoplasm: We also showed that pharmacological inhibition of PKLR decreases tumor growth and NED progression in multiple in vitro and in vivo models of ADT-resistant and NE-like PCa cells, pointing to a potential approach for treating therapeutic-resistant PCa.